Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination
Ariane Sternberg, Cord Naujokat
Life Sciences (2020) Vol. 257, pp. 118056-118056
Open Access | Times Cited: 222

Showing 26-50 of 222 citing articles:

Immune Epitopes of SARS-CoV-2 Spike Protein and Considerations for Universal Vaccine Development
Nicholas Magazine, Tianyi Zhang, Anang D. Bungwon, et al.
ImmunoHorizons (2024) Vol. 8, Iss. 3, pp. 214-226
Open Access | Times Cited: 10
Exploring lectin–glycan interactions to combat COVID-19: Lessons acquired from other enveloped viruses
Luís Cláudio Nascimento da Silva, Juliana Silva Pereira Mendonça, Weslley Felix de Oliveira, et al.
Glycobiology (2020) Vol. 31, Iss. 4, pp. 358-371
Open Access | Times Cited: 64
The influence of ABO blood groups on COVID-19 susceptibility and severity: A molecular hypothesis based on carbohydrate-carbohydrate interactions
J.C. Silva-Filho, Cynthia Germoglio Farias de Melo, Janaína Lima de Oliveira
Medical Hypotheses (2020) Vol. 144, pp. 110155-110155
Open Access | Times Cited: 56
An overview of potential inhibitors targeting non-structural proteins 3 (PLpro and Mac1) and 5 (3CLpro/Mpro) of SARS-CoV-2
Fangfang Yan, Feng Gao
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 4868-4883
Open Access | Times Cited: 49
Expression and characterization of SARS-CoV-2 spike proteins
Jeffrey M. Schaub, Chia‐Wei Chou, Hung-Che Kuo, et al.
Nature Protocols (2021) Vol. 16, Iss. 11, pp. 5339-5356
Open Access | Times Cited: 49
Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment
Norma A. Valdez‐Cruz, Enrique Garcı́a-Hernández, Clara Espitia, et al.
Microbial Cell Factories (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 48
Inhibition of HECT E3 ligases as potential therapy for COVID-19
Giuseppe Novelli, Jing Liu, Michela Biancolella, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 4
Open Access | Times Cited: 47
Molecular optimization, docking, and dynamic simulation profiling of selective aromatic phytochemical ligands in blocking the SARS-CoV-2 S protein attachment to ACE2 receptor: an in silico approach of targeted drug designing
Dipta Dey, Parag Kumar Paul, Salauddin Al Azad, et al.
Journal of Advanced Veterinary and Animal Research (2021) Vol. 8, Iss. 1, pp. 1-1
Open Access | Times Cited: 46
Development of a Vaccine against SARS-CoV-2 Based on the Receptor-Binding Domain Displayed on Virus-Like Particles
Lisha Zha, Xinyue Chang, Hongxin Zhao, et al.
Vaccines (2021) Vol. 9, Iss. 4, pp. 395-395
Open Access | Times Cited: 46
Computer Aided Drug Design Approach to Screen Phytoconstituents of Adhatoda vasica as Potential Inhibitors of SARS-CoV-2 Main Protease Enzyme
B. Sivakumar, Anuragh Singh, Ananth Kumar Kammala, et al.
Life (2022) Vol. 12, Iss. 2, pp. 315-315
Open Access | Times Cited: 36
Progress in Electrochemical Biosensing of SARS-CoV-2 Virus for COVID-19 Management
Md. Mahbubur Rahman
Chemosensors (2022) Vol. 10, Iss. 7, pp. 287-287
Open Access | Times Cited: 32
Design of a mutation-integrated trimeric RBD with broad protection against SARS-CoV-2
Yu Liang, Jing Zhang, Run Yu Yuan, et al.
Cell Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 31
Quantitative profiling of N-glycosylation of SARS-CoV-2 spike protein variants
Yongjing Xie, Michael Butler
Glycobiology (2023) Vol. 33, Iss. 3, pp. 188-202
Open Access | Times Cited: 18
ViPRA-Haplo: De Novo Reconstruction of Viral Populations Using Paired End Sequencing Data
Weiling Li, Raunaq Malhotra, Steven Wu, et al.
IEEE/ACM Transactions on Computational Biology and Bioinformatics (2024) Vol. 21, Iss. 3, pp. 492-500
Closed Access | Times Cited: 8
Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based Study
Anna Schaffner, Lorenz Risch, Stefanie Aeschbacher, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 12, pp. 3989-3989
Open Access | Times Cited: 48
Dangerous Pathogens as a Potential Problem for Public Health
Edyta Janik, Michał Ceremuga, Marcin Niemcewicz, et al.
Medicina (2020) Vol. 56, Iss. 11, pp. 591-591
Open Access | Times Cited: 41
Research advances and prospects of legume lectins
Rajan Katoch, Ankur Tripathi
Journal of Biosciences (2021) Vol. 46, Iss. 4
Open Access | Times Cited: 37
Polymersomes Decorated with the SARS-CoV-2 Spike Protein Receptor-Binding Domain Elicit Robust Humoral and Cellular Immunity
Lisa R. Volpatti, Rachel P. Wallace, Shijie Cao, et al.
ACS Central Science (2021) Vol. 7, Iss. 8, pp. 1368-1380
Open Access | Times Cited: 34
Developing an Optical Interferometric Detection Method based biosensor for detecting specific SARS-CoV-2 immunoglobulins in Serum and Saliva, and their corresponding ELISA correlation
Ana M. Murillo, Jaime Tomé‐Amat, Yolanda Ramírez, et al.
Sensors and Actuators B Chemical (2021) Vol. 345, pp. 130394-130394
Open Access | Times Cited: 33
Antimicrobial Resistance in the COVID-19 Landscape: Is There an Opportunity for Anti-Infective Antibodies and Antimicrobial Peptides?
José Manuel Pérez de la Lastra, Uttpal Anand, Sergio González-Acosta, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26
S Protein, ACE2 and Host Cell Proteases in SARS-CoV-2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword? A Narrative Review
Reza Nejat, Maziar Fayaz Torshizi, David J. Najafi
Vaccines (2023) Vol. 11, Iss. 2, pp. 204-204
Open Access | Times Cited: 16
Quinones as Promising Compounds against Respiratory Viruses: A Review
Iván Chan‐Zapata, Rocı́o Borges-Argáez, Guadalupe Ayora‐Talavera
Molecules (2023) Vol. 28, Iss. 4, pp. 1981-1981
Open Access | Times Cited: 15
The Coming of Age of Nucleic Acid Vaccines during COVID-19
Halie M. Rando, Ronan Lordan, Likhitha Kolla, et al.
mSystems (2023) Vol. 8, Iss. 2
Open Access | Times Cited: 14
SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments
Gisela Canedo-Marroquín, Farides Saavedra, Catalina A. Andrade, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 36
Ad26-vector based COVID-19 vaccine encoding a prefusion stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses
Rinke Bos, Lucy Rutten, Joan E. M. van der Lubbe, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 33

Scroll to top